skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,923  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Clinical Trials remove subject: Pharmaceutical Industry remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
Material Type:
Article
Add to My Research

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials

JAMA : the journal of the American Medical Association, 2017-12, Vol.318 (23), p.2337 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2017.18556 ;PMID: 29260229

Digital Resources/Online E-Resources

2
Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise
Material Type:
Article
Add to My Research

Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise

Nature reviews. Clinical oncology, 2020-02, Vol.17 (2), p.91-107 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;2019© Springer Nature Limited 2019 ;Springer Nature Limited 2019. ;Copyright ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-019-0267-4 ;PMID: 31570827

Full text available

3
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Material Type:
Article
Add to My Research

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033 [Peer Reviewed Journal]

2018 American Association for Clinical Chemistry. ;COPYRIGHT 2018 American Association for Clinical Chemistry, Inc. ;Copyright American Association for Clinical Chemistry Jul 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2018.287037 ;PMID: 29760220

Full text available

4
Alzheimer's disease drug development pipeline: 2022
Material Type:
Article
Add to My Research

Alzheimer's disease drug development pipeline: 2022

Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12295-n/a [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals, LLC on behalf of Alzheimer's Association ;2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12295 ;PMID: 35516416

Full text available

5
Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment
Material Type:
Article
Add to My Research

Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment

PloS one, 2021-10, Vol.16 (10), p.e0258858-e0258858 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0258858 ;PMID: 34665829

Full text available

6
Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals
Material Type:
Article
Add to My Research

Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals

PLoS medicine, 2013-12, Vol.10 (12), p.e1001566; discussion e1001566-e1001566; discussion e1001566 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Riveros et al 2013 Riveros et al ;2013 Riveros et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, et al. (2013) Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals. PLoS Med 10(12): e1001566. doi:10.1371/journal.pmed.1001566 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1001566 ;PMID: 24311990

Full text available

7
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
Material Type:
Article
Add to My Research

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Intensive care medicine, 2023-02, Vol.49 (2), p.178-190 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2023. Springer-Verlag GmbH Germany, part of Springer Nature. ;COPYRIGHT 2023 Springer ;Distributed under a Creative Commons Attribution 4.0 International License ;Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0342-4642 ;ISSN: 1432-1238 ;EISSN: 1432-1238 ;DOI: 10.1007/s00134-022-06944-2 ;PMID: 36764959

Full text available

8
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
Material Type:
Article
Add to My Research

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

Orphanet journal of rare diseases, 2015-09, Vol.10 (1), p.109-109, Article 109 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Distributed under a Creative Commons Attribution 4.0 International License ;Suhr et al. 2015 ;ISSN: 1750-1172 ;EISSN: 1750-1172 ;DOI: 10.1186/s13023-015-0326-6 ;PMID: 26338094

Full text available

9
Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research
Material Type:
Article
Add to My Research

Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research

PloS one, 2017-04, Vol.12 (4), p.e0176210-e0176210 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Schmucker et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Schmucker et al 2017 Schmucker et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0176210 ;PMID: 28441452

Full text available

10
Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials
Material Type:
Article
Add to My Research

Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

Infectious diseases of poverty, 2021-07, Vol.10 (1), p.94-94, Article 94 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2049-9957 ;ISSN: 2095-5162 ;EISSN: 2049-9957 ;DOI: 10.1186/s40249-021-00878-5 ;PMID: 34225791

Full text available

11
Alzheimer's disease drug development pipeline: 2023
Material Type:
Article
Add to My Research

Alzheimer's disease drug development pipeline: 2023

Alzheimer's & dementia : translational research & clinical interventions, 2023-04, Vol.9 (2), p.e12385-n/a [Peer Reviewed Journal]

2023 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association. ;2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12385 ;PMID: 37251912

Full text available

12
Subcutaneous Methylnaltrexone as Treatment for Opioid-lnduced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials
Material Type:
Article
Add to My Research

Subcutaneous Methylnaltrexone as Treatment for Opioid-lnduced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials

Journal of pain research, 2023-02, Vol.16, p.395 [Peer Reviewed Journal]

COPYRIGHT 2023 Dove Medical Press Limited ;ISSN: 1178-7090 ;EISSN: 1178-7090 ;DOI: 10.2147/JPR.S36646

Full text available

13
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study
Material Type:
Article
Add to My Research

Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study

The journal of clinical endocrinology and metabolism, 2021-05, Vol.106 (5), p.e2347-e2356 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 ;Copyright © Oxford University Press 2015 ;The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;COPYRIGHT 2021 Oxford University Press ;The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgaa748 ;PMID: 33075806

Full text available

14
The use of RNA-based treatments in the field of cancer immunotherapy
Material Type:
Article
Add to My Research

The use of RNA-based treatments in the field of cancer immunotherapy

Molecular cancer, 2023-07, Vol.22 (1), p.106-106, Article 106 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-023-01807-w ;PMID: 37420174

Full text available

15
The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials
Material Type:
Article
Add to My Research

The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials

Oncology, 2021-06, Vol.99 (7), p.444-453 [Peer Reviewed Journal]

2021 The Author(s) Published by S. Karger AG, Basel ;2021 The Author(s) Published by S. Karger AG, Basel. ;COPYRIGHT 2021 S. Karger AG ;ISSN: 0030-2414 ;EISSN: 1423-0232 ;DOI: 10.1159/000514874 ;PMID: 33823518

Digital Resources/Online E-Resources

16
Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer
Material Type:
Article
Add to My Research

Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer

The oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.290-e545 [Peer Reviewed Journal]

AlphaMed Press; the data published online to support this summary are the property of the authors. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13631 ;PMID: 33296125

Full text available

17
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
Material Type:
Article
Add to My Research

Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database

International journal of general medicine, 2021-07, Vol.14, p.3909-3927 [Peer Reviewed Journal]

COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Jeet Kaur et al. 2021 Jeet Kaur et al. ;ISSN: 1178-7074 ;EISSN: 1178-7074 ;DOI: 10.2147/IJGM.S324349 ;PMID: 34349544

Full text available

18
BATTLING 'SLUDGE' IN CLINICAL TRIALS: A CALL TO ACTION
Material Type:
Article
Add to My Research

BATTLING 'SLUDGE' IN CLINICAL TRIALS: A CALL TO ACTION

Applied clinical trials, 2024-04, Vol.33 (4), p.10-11 [Peer Reviewed Journal]

COPYRIGHT 2024 Intellisphere, LLC ;Copyright MultiMedia Healthcare Inc. Apr 2024 ;ISSN: 1064-8542 ;EISSN: 2150-623X

Digital Resources/Online E-Resources

19
Exploring PI3K[delta] Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled Trials
Material Type:
Article
Add to My Research

Exploring PI3K[delta] Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled Trials

International journal of chronic obstructive pulmonary disease, 2021-06, Vol.16, p.1621 [Peer Reviewed Journal]

COPYRIGHT 2021 Dove Medical Press Limited ;ISSN: 1178-2005 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S309303

Full text available

20
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine
Material Type:
Article
Add to My Research

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine

PLoS medicine, 2022-05, Vol.19 (5) [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003953

Full text available

Results 1 - 20 of 1,923  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2004  (8)
  2. 2004 To 2008  (145)
  3. 2009 To 2013  (452)
  4. 2014 To 2019  (348)
  5. After 2019  (972)
  6. More options open sub menu

Language 

  1. English  (1,922)
  2. Japanese  (33)
  3. French  (1)
  4. Spanish  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait